On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical Isotopes (IAMI), Canada’s first nuclear medicine hub.

IAMI will be part of TRIUMF at the University of British Columbia campus and will house BC Cancer and other industry partners to advance medical isotope production, drug development, cancer therapy, clinical imaging and radiopharmaceutical research.

Over the next five years, BC Cancer will scale up scientific development of radioactive isotope treatments and launch a series of clinical trials. The first patient trials are well within reach in the year ahead.